Squamous Cell Carcinoma of the Skin has More Than Doubled Over the Last Decade in the UK

被引:19
作者
Goon, Peter K. C. [1 ]
Greenberg, David C. [2 ]
Igali, Laszlo [3 ]
Levell, Nick J. [1 ]
机构
[1] Norfolk & Norwich Univ Hosp, Dept Dermatol, Colney Lane, Norwich NR4 7UY, Norfolk, England
[2] Norfolk & Norwich Univ Hosp, Dept Pathol, Colney Lane, Norwich NR4 7UY, Norfolk, England
[3] Publ Hlth England, Natl Canc Registrat Serv, Unit C, Cambridge, England
关键词
BASAL-CELL; CANCER; COST;
D O I
10.2340/00015555-2310
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Epidemiological data on a very common skin cancer, squamous cell carcinoma (SCC), are lacking in the UK. Rates of SCC of the skin worldwide appear to be increasing (1–3) but accurate data in many countries are lacking due to incomplete cancer registration. The problems encountered include multiple cancer diagnoses, duplicate reports, reporting delays, misclassification of race/ethnicity, and pitfalls in estimations of cancer incidence rates (4). Common practices in the UK include only registering the first case of non-melanoma skin cancer (NMSC) in an individual patient, with non-inclusion of subsequent tumours and nondifferentiation of multiple tumours. Cancer registry data from all home countries in the UK for 2011 showed there were 102,628 cases of NMSC registered: 57,800 (56%) in men and 44,828 (44%) in women, giving a male:female ratio of around 1.3:1. The majority of NMSCs are either basal cell carcinomas (BCCs) or SCCs. We have shown previously (5) that BCC cancer registry data represent a 2.0–2.2 fold underestimate of real incidence rates in the UK, due to the registration practices mentioned. The aim of this work was to estimate the number of SCCs of the skin requiring surgical treatment in this region, and in the UK each year, and to compare these data with those collected by our cancer registries. © 2016 The Authors.
引用
收藏
页码:820 / 821
页数:2
相关论文
共 9 条
[1]  
Athas WF, 2003, CANCER EPIDEM BIOMAR, V12, P1105
[2]  
CRUK, 2014, 20 MOST COMM CANC UK
[3]   The potential and limitations of data from population-based state cancer registries [J].
Izquierdo, JN ;
Schoenbach, VJ .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (05) :695-698
[4]   NONMELANOMA SKIN-CANCER - 10 YEARS OF CANCER-REGISTRY-BASED SURVEILLANCE [J].
KALDOR, J ;
SHUGG, D ;
YOUNG, B ;
DWYER, T ;
WANG, YG .
INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (06) :886-891
[5]  
Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO
[6]  
2-R
[7]   Basal cell carcinoma epidemiology in the UK: the elephant in the room [J].
Levell, N. J. ;
Igali, L. ;
Wright, K. A. ;
Greenberg, D. C. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2013, 38 (04) :367-369
[8]   Economic burden of cancer across the European Union: a population-based cost analysis [J].
Luengo-Fernandez, Ramon ;
Leal, Jose ;
Gray, Alastair ;
Sullivan, Richard .
LANCET ONCOLOGY, 2013, 14 (12) :1165-1174
[9]   Measuring current and future cost of skin cancer in England [J].
Vallejo-Torres, L. ;
Morris, S. ;
Kinge, J. M. ;
Poirier, V. ;
Verne, J. .
JOURNAL OF PUBLIC HEALTH, 2014, 36 (01) :140-148